Effect of 5-Minute Movies Shown via a Mobile Phone App on Risk Factors and Mortality After Stroke in a Low- to Middle-Income Country: Randomized Controlled Trial for the Stroke Caregiver Dyad Education Intervention (Movies4Stroke).
adherence
mobile health
noncommunicable diseases
stroke
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
28 01 2020
28 01 2020
Historique:
received:
05
09
2018
accepted:
19
07
2019
revised:
01
03
2019
entrez:
4
2
2020
pubmed:
6
2
2020
medline:
2
4
2021
Statut:
epublish
Résumé
Pakistan is the sixth most populous nation in the world and has an estimated 4 million stroke survivors. Most survivors are taken care of by community-based caregivers, and there are no inpatient rehabilitation facilities. The objective of this study was to evaluate the effectiveness and safety of locally designed 5-min movies rolled out in order of relevance that are thematically delivered in a 3-month program to deliver poststroke education to stroke survivor and caregiver dyads returning to the community. This study was a randomized controlled, outcome assessor-blinded, parallel group, single-center superiority trial in which participants (stroke survivor-caregiver dyads) with first-ever stroke (both ischemic and hemorrhagic) incidence were randomized within 48 hours of their stroke into either the video-based education intervention group or the control group. The video-based education intervention group had health education delivered through short videos that were shown to the participants and their caregivers at the time of admission, before discharge, and the first and third months of follow-up after discharge. The control group had standardized care including predischarge education and counseling according to defined protocols. All participants enrolled in the video education intervention and control groups were followed for 12 months after discharge for outcome assessment in the outpatient stroke clinics. The primary outcome measures were the proportion of participants achieving control of blood pressure, blood sugar, and blood cholesterol in the video intervention versus the control group. Several predefined secondary outcomes were included in this study, of which we report the mortality and functional disability in this paper. Analysis was by performed using the intention-to-treat principle. A total of 310 stroke survivors and their caregiver dyads (participant dyads) were recruited over a duration of 6 months. In total, 155 participant dyads were randomized into the intervention and control groups, each. The primary outcome of control of three major risk factors revealed that at 12 months, there was a greater percentage of participants with a systolic BP<125 mm Hg (18/54, 33% vs 11/52, 21%; P=.16), diastolic BP<85 mm Hg (44/54, 81% vs 37/52, 71%; P=.21), HbA The Movies4Stroke trial failed to achieve its primary specified outcome. However, secondary outcomes that directly related to survival skills of stroke survivors demonstrated the effectiveness of the video-based intervention on improving stroke-related mortality and survival without disability. ClinicalTrials.gov NCT02202330; https://www.clinicaltrials.gov/ct2/show/NCT02202330.
Sections du résumé
BACKGROUND
Pakistan is the sixth most populous nation in the world and has an estimated 4 million stroke survivors. Most survivors are taken care of by community-based caregivers, and there are no inpatient rehabilitation facilities.
OBJECTIVE
The objective of this study was to evaluate the effectiveness and safety of locally designed 5-min movies rolled out in order of relevance that are thematically delivered in a 3-month program to deliver poststroke education to stroke survivor and caregiver dyads returning to the community.
METHODS
This study was a randomized controlled, outcome assessor-blinded, parallel group, single-center superiority trial in which participants (stroke survivor-caregiver dyads) with first-ever stroke (both ischemic and hemorrhagic) incidence were randomized within 48 hours of their stroke into either the video-based education intervention group or the control group. The video-based education intervention group had health education delivered through short videos that were shown to the participants and their caregivers at the time of admission, before discharge, and the first and third months of follow-up after discharge. The control group had standardized care including predischarge education and counseling according to defined protocols. All participants enrolled in the video education intervention and control groups were followed for 12 months after discharge for outcome assessment in the outpatient stroke clinics. The primary outcome measures were the proportion of participants achieving control of blood pressure, blood sugar, and blood cholesterol in the video intervention versus the control group. Several predefined secondary outcomes were included in this study, of which we report the mortality and functional disability in this paper. Analysis was by performed using the intention-to-treat principle.
RESULTS
A total of 310 stroke survivors and their caregiver dyads (participant dyads) were recruited over a duration of 6 months. In total, 155 participant dyads were randomized into the intervention and control groups, each. The primary outcome of control of three major risk factors revealed that at 12 months, there was a greater percentage of participants with a systolic BP<125 mm Hg (18/54, 33% vs 11/52, 21%; P=.16), diastolic BP<85 mm Hg (44/54, 81% vs 37/52, 71%; P=.21), HbA
CONCLUSIONS
The Movies4Stroke trial failed to achieve its primary specified outcome. However, secondary outcomes that directly related to survival skills of stroke survivors demonstrated the effectiveness of the video-based intervention on improving stroke-related mortality and survival without disability.
TRIAL REGISTRATION
ClinicalTrials.gov NCT02202330; https://www.clinicaltrials.gov/ct2/show/NCT02202330.
Identifiants
pubmed: 32012080
pii: v8i1e12113
doi: 10.2196/12113
pmc: PMC7013656
doi:
Substances chimiques
Tissue Plasminogen Activator
EC 3.4.21.68
Banques de données
ClinicalTrials.gov
['NCT02202330']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12113Informations de copyright
©Ayeesha Kamal, Adeel Khoja, Bushra Usmani, Shahvaiz Magsi, Aresha Malani, Zahra Peera, Saadia Sattar, Masood Ahmed Akram, Sumaira Shahnawaz, Maryam Zulfiqar, Abdul Muqeet, Fabiha Zaidi, Saleem Sayani, Azmina Artani, Iqbal Azam, Sarah Saleem. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 28.01.2020.
Références
Stroke. 2016 Jun;47(6):e98-e169
pubmed: 27145936
Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008656
pubmed: 23543566
Neurol Neurochir Pol. 2005 Jul-Aug;39(4):300-9
pubmed: 16096935
J Psychosom Res. 2014 May;76(5):430-2
pubmed: 24745787
Trials. 2016 Jan 27;17:52
pubmed: 26818913
NeuroRehabilitation. 2017;40(2):223-232
pubmed: 28222545
Lancet Neurol. 2006 Jul;5(7):603-12
pubmed: 16781990
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Clin Rehabil. 2015 Nov;29(11):1129-40
pubmed: 25552525
Lancet. 2013 Dec 21;382(9910):2069-76
pubmed: 24054816
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD008179
pubmed: 21975778
Lancet. 2017 Aug 5;390(10094):588-599
pubmed: 28666682
PLoS One. 2017 Mar 23;12(3):e0171952
pubmed: 28333925
Ann Intern Med. 2008 Feb 19;148(4):295-309
pubmed: 18283207
J Telemed Telecare. 2015 Apr;21(3):139-43
pubmed: 25680390
J Adv Nurs. 2009 Jan;65(1):217-28
pubmed: 19032518
Neuropharmacology. 2000 Mar 3;39(5):835-41
pubmed: 10699448
BMC Res Notes. 2012 Feb 09;5:89
pubmed: 22321339
Arch Neurol. 2004 Nov;61(11):1677-80
pubmed: 15534178
Can J Neurol Sci. 2011 Mar;38(2):317-34
pubmed: 21320840
Lancet Neurol. 2009 Apr;8(4):355-69
pubmed: 19233729
Lancet. 2013 Feb 16;381(9866):566-74
pubmed: 23410606
Stroke. 1988 Dec;19(12):1497-500
pubmed: 3201508
Health Educ Q. 1988 Summer;15(2):175-83
pubmed: 3378902
Lancet Neurol. 2016 Aug;15(9):913-924
pubmed: 27291521
J Hum Hypertens. 2006 Jan;20(1):83-5
pubmed: 16151442
JAMA. 2015 Sep 22-29;314(12):1255-63
pubmed: 26393848
Lancet Neurol. 2015 Sep;14(9):893-902
pubmed: 26231624
J Med Internet Res. 2011 Dec 31;13(4):e126
pubmed: 22209829
Neurorehabil Neural Repair. 2005 Jun;19(2):133-8
pubmed: 15883357
PLoS Med. 2015 Sep 08;12(9):e1001872
pubmed: 26349050
Ophthalmic Res. 2016;56(3):111-22
pubmed: 27352292
Lancet. 2011 Apr 23;377(9775):1438-47
pubmed: 21474174
Arch Phys Med Rehabil. 2011 Jan;92(1):161-6
pubmed: 21187218